IL6 and breast cancer: Additionally, it has been highlighted that the potential diagnostic function of lncRNA H-19 and miR-200a in BC as well as the association of IL-6/SIRT-1 with lncRNA H-19/miR-200a expression could be a promising opportunity for clinical outcomes and tailored treatments [147].